EGFL6 and central nervous system cancer: Recently, several human tumor biopsy transcription analyses have indicated egfl6 mRNA is expressed at high levels in meningioma, glioma and ovarian and breast carcinomas, while levels in normal tissues were virtually undetectable [6,8,11–13].